Hong Kong Pharma Digital Technology Holdings Limited Ordinary sharesHKPD
About: Hong Kong Pharma Digital Technology Holdings Ltd operates in two main categories: (i) OTC pharmaceutical cross-border e-commerce supply chain services, conducted through its Hong Kong subsidiary, Joint Cross Border, which it refers to as the Supply Chain Services division, and (ii) OTC pharmaceutical cross-border procurement and distribution, conducted through its Hong Kong subsidiary, V-Alliance, which it referred to as the Procurement and Distribution division. Based in Hong Kong, Joint Cross Border has established itself as a provider of third-party supply chain services in Mainland China's OTC pharmaceutical cross-border e-commerce market.
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
0.47% more ownership
Funds ownership: 0% [Q4 2024] → 0.47% (+0.47%) [Q1 2025]
Research analyst outlook
We haven’t received any recent analyst ratings for HKPD.
Financial journalist opinion


